mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |